Amendment To Distribution Agreement Sample Contracts

Amendment to Distribution Agreement (March 9th, 2018)
Third Amendment to Distribution Agreement (March 5th, 2018)

Corporation ("Vericel") and Orsini Pharmaceutical Services, Inc. ("Orsini"). This Third Amendment is effective as of November 14, 2017 ("Effective Date").

Second Amendment to Distribution Agreement (March 5th, 2018)

This Second Amendment to the Distribution Agreement ("Second Amendment") is between Vericel Corporation ("Vericel") and Orsini Pharmaceutical Services, Inc. ("Orsini"). This Second Amendment is effective as of October 13, 2017 ("Effective Date").

Ameriprise Certificate Co – Amendment to Distribution Agreement (February 23rd, 2018)

This Amendment to the Distribution Agreement, dated as of January 25, 2018 (the "Amendment"), is between Ameriprise Certificate Company (the "Company") and Ameriprise Financial Services, Inc. ("AMPF"), and amends the Distribution Agreement, dated as of December 31, 2006 and amended as of May 15, 2012, September 19, 2014 and May 8, 2015 (the "Agreement"), between the Company and AMPF.

First Amendment to Distribution Agreement (November 7th, 2017)

This First Amendment to the Distribution Agreement ("Amendment") is between Vericel Corporation ("Vericel") and Orsini Pharmaceutical Services, Inc. ("Orsini"). This Amendment is effective as of August 10, 2017 ("Effective Date").

Deere John Capital Corp – JOHN DEERE CAPITAL CORPORATION JDCC InterNotes(r) Due Nine Months or More From Date of Issue AMENDMENT TO DISTRIBUTION AGREEMENT (April 10th, 2017)

Reference is made to the Distribution Agreement dated as of February 26, 2009, as amended by the Assignment and Acceptance Agreement dated as of August 12, 2009, an amendment dated as of April 21, 2011 and an amendment dated as of April 17, 2014 (together, the Distribution Agreement) between John Deere Capital Corporation (the Company), InCapital LLC (the Purchasing Agent) and Merrill Lynch, Pierce, Fenner & Smith Incorporated (the Agent). The Company, the Purchasing Agent and the Agent agree as follows:

Senseonics Holdings, Inc. – Amendment to Distribution Agreement (February 23rd, 2017)

This Amendment to Distribution Agreement ("Amendment") is effective as of November 28, 2016 (the "Amendment Effective Date"), by and between Roche Diagnostics International AG, Basel Branch Diabetes Care, with offices located at Peter Merian-Weg 4, 4052 Basel, Switzerland ("Roche Diagnostics") and Roche Diabetes Care GmbH, with offices located at Sandhofer Strasse 116, 68305 Mannheim, Germany ("Roche Diabetes" and collectively with Roche Diagnostics, "Roche") and Senseonics Incorporated, with offices located at 20451 Seneca Meadows Parkway, Germantown, MD 20876-7005, USA ("Senseonics"). Roche and Senseonics are sometimes referred to herein individually as a "Party" and collectively as the "Parties."

Fourth Amendment to Distribution Agreement (TYVASO(r)) (February 22nd, 2017)

THIS FOURTH AMENDMENT TO DISTRIBUTION AGREEMENT (this Third Amendment) is made and effective November 1, 2016 (the Fourth Amendment Effective Date) by and among, United Therapeutics Corporation, a Delaware corporation having offices at 1040 Spring Street, Silver Spring, Maryland (UT), Accredo Health Group, Inc., a Delaware corporation having offices at 6272 Lee Vista Boulevard, Orlando FL, 32822 (Accredo), and Priority Healthcare Distribution, Inc., doing business as CuraScript SD Specialty Distribution, a Florida corporation with offices at 255 Technology Park, Lake Mary, Florida, 32746 (SD). SP, SD and Accredo are collectively referred to herein as the Distributor.

Ameriprise Certificate Co – Third Amendment to Distribution Agreement (August 3rd, 2015)

This Third Amendment to the Distribution Agreement, dated as of May 8, 2015 (the "Amendment"), is between Ameriprise Certificate Company (the "Company") and Ameriprise Financial Services, Inc. ("AMPF"), and amends the Distribution Agreement, dated as of December 31, 2006 and amended as of May 15, 2012 and September 19, 2014 (the "Agreement"), between the Company and AMPF.

Oasmia Pharmaceutical AB – First Amendment to Distribution Agreement Between Oasmia Pharmaceutical Ab and Abbott Laboratories (June 12th, 2015)

This First Amendment ("First Amendment") to the Distribution Agreement, dated as of July 8, 2009, between Abbott Laboratories, an Illinois corporation ("Abbott"), and Oasmia Pharmaceutical AB, a Swedish corporation ("Oasmia") (the "Original Agreement"), is effective as of December ___, 2012 ("First Amendment Effective Date"). Any capitalized term used and not otherwise defined herein shall have the meaning set forth in the Original Agreement.

Third Amendment to Distribution Agreement (TYVASO(r)) (February 24th, 2015)

THIS THIRD AMENDMENT TO DISTRIBUTION AGREEMENT (this Third Amendment) is made and effective this 20th Day of October, 2014 (the Third Amendment Effective Date) by and among, United Therapeutics Corporation, a Delaware corporation having offices at 1040 Spring Street, Silver Spring, Maryland (UT), Accredo Health Group, Inc., a Delaware corporation having offices at 6272 Lee Vista Boulevard, Orlando FL, 32822 (Accredo), CuraScript, Inc., a Delaware corporation having offices at 6272 Lee Vista Boulevard, Orlando FL, 32822 (SP) and Priority Healthcare Distribution, Inc., doing business as CuraScript SD Specialty Distribution, a Florida corporation with offices at 255 Technology Park, Lake Mary, Florida, 32746 (SD). SP, SD and Accredo are collectively referred to herein as the Distributor.

Ameriprise Certificate Co – Second Amendment to Distribution Agreement (November 14th, 2014)

This Second Amendment to the Distribution Agreement, dated as of September 19, 2014 (the Amendment), is between Ameriprise Certificate Company (the Company) and Ameriprise Financial Services, Inc. (AMPF), and amends the Distribution Agreement, dated as of December 31, 2006 and amended as of May 15, 2012 (the Agreement), between the Company and AMPF.

Ameriprise Certificate Co – Second Amendment to Distribution Agreement (November 3rd, 2014)

This Second Amendment to the Distribution Agreement, dated as of September 19, 2014 (the "Amendment"), is between Ameriprise Certificate Company (the "Company") and Ameriprise Financial Services, Inc. ("AMPF"), and amends the Distribution Agreement, dated as of December 31, 2006 and amended as of May 15, 2012 (the "Agreement"), between the Company and AMPF.

First Amendment to Distribution Agreement (October 28th, 2014)

This FIRST AMENDMENT TO DISTRIBUTION AGREEMENT (this First Amendment) is entered into as of May 18, 2011, by and between (i) STARCH MEDICAL, INC., a Delaware corporation having a principal place of business at 2150 Ringwood Avenue, San Jose, California 95131 (SMI), (ii) CRYOLIFE, INC., a Florida corporation, having a principal place of business at 1655 Roberts Blvd. NW, Kennesaw, Georgia 30144 (CryoLife) and (iii) CLOTPLUS LIMITED, a limited company of Ireland having a principal place of business at Regus House, Block 4, Harcourt Road, Dublin2, Ireland (CPL). This First Amendment amends that certain Distribution Agreement dated September 28, 2010 between SMI and CryoLife (the Agreement) and adds CPL as a party for the limited purposes set forth in this First Amendment. When used herein, the term Amended Agreement refers to the Agreement as amended by this First Amendment. To the extent any provision of this First Amendment conflicts with a term of the Agreement, the provisions of this

Cardica, Inc. – Fifth Amendment to Distribution Agreement (September 25th, 2014)

This FIFTH AMENDMENT TO DISTRIBUTION AGREEMENT (this "Amendment") is made and entered into as of July 1, 2014 (the "Effective Amendment Date") by and between Century Medical, Inc., a Japanese corporation with its principal place of business located at 1-11-2, Ohsaki, Shinagawa-Ku, Tokyo 141-8588, Japan ("DISTRIBUTOR"), and Cardica, Inc., a Delaware corporation with its principal place of business located at 900 Saginaw Drive, Redwood City, California 94063 USA ("COMPANY").

Deere John Capital Corp – JOHN DEERE CAPITAL CORPORATION JDCC InterNotes(r) Due Nine Months or More From Date of Issue AMENDMENT TO DISTRIBUTION AGREEMENT (April 22nd, 2014)

Reference is made to the Distribution Agreement dated as of February 26, 2009, as amended by the Assignment and Acceptance Agreement dated as of August 12, 2009 and an amendment dated as of April 21, 2011 (together, the Distribution Agreement) between John Deere Capital Corporation (the Company), Incapital LLC (the Purchasing Agent) and Merrill Lynch, Pierce, Fenner & Smith Incorporated (the Agent). The Company, the Purchasing Agent and the Agent agree as follows:

Green Automotive Co – Summary of Amendment to Distribution Agreement by and Between Newport Coachworks, Inc. And Don Brown Bus Sales, Inc. Dated November 1, 2012 (November 29th, 2013)

On November 1, 2012, Newport Coachworks, Inc. entered into a Distribution Agreement with Don Brown Bus Sales, Inc., under which Down Brown placed an initial order with Newport Coachworks for Newport Coachworks to manufacture 288 buses between December 2012 and December 2014.

Second Amendment to Distribution Agreement (October 29th, 2013)

This SECOND AMENDMENT TO DISTRIBUTION AGREEMENT (this Second Amendment) is entered into as of September 20, 2013, by and between STARCH MEDICAL, INC., a Delaware corporation having a principal place of business at 2150 Ringwood Avenue, San Jose, California 95131(SMI) and CRYOLIFE, INC., a Florida corporation, having a principal place of business at 1655 Roberts Blvd. NW, Kennesaw, Georgia 30144 (CryoLife).

Amendment to Distribution Agreement Between Avaya, Inc. And Scansource, Inc. D/B/A Catalyst Telecom Master Terms and Conditions (August 26th, 2013)

This Amendment dated ***** is entered into by and between Avaya, Inc. ("Avaya"), a Delaware corporation, with offices at 211 Mt. Airy Road, Basking Ridge, NJ 07920, and ScanSource, Inc. d/b/a Catalyst Telecom ("Distributor"), a South Carolina corporation, with its principal place of business at 6 Logue Court, Greenville, SC 29615.

SECOND AMENDMENT TO DISTRIBUTION AGREEMENT February 17, 2012 (July 3rd, 2013)

For good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Sprouts Farmers Markets (SFM) and Natures Best (NB) agree to the following amendments to their Distribution Agreement dated April 14, 2010, as previously amended as of May 31, 2011 (Distribution Agreement):

THIRD AMENDMENT TO DISTRIBUTION AGREEMENT July 6, 2012 (July 3rd, 2013)

For good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Sprouts Farmers Markets (SFM) and Natures Best (NB) agree to the following amendments to their Distribution Agreement dated April 14, 2010, as previously amended as of May 31, 2011 and February 17, 2012 (Distribution Agreement):

SECOND AMENDMENT TO DISTRIBUTION AGREEMENT February 17, 2012 (June 17th, 2013)

For good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Sprouts Farmers Markets (SFM) and Natures Best (NB) agree to the following amendments to their Distribution Agreement dated April 14, 2010, as previously amended as of May 31, 2011 (Distribution Agreement):

THIRD AMENDMENT TO DISTRIBUTION AGREEMENT July 6, 2012 (June 17th, 2013)

For good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Sprouts Farmers Markets (SFM) and Natures Best (NB) agree to the following amendments to their Distribution Agreement dated April 14, 2010, as previously amended as of May 31, 2011 and February 17, 2012 (Distribution Agreement):

Confidential Treatment Requested [***] - Confidential Portions of This Agreement Which Have Been Redacted Are Marked With Brackets ("[***]"). The Omitted Material Has Been Filed Separately With the United States Securities and Exchange Commission. First Amendment to Distribution Agreement (January 30th, 2012)

This FIRST AMENDMENT TO DISTRIBUTION AGREEMENT (this "First Amendment") is entered into as of May 18, 2011, by and between (i) STARCH MEDICAL, INC., a Delaware corporation having a principal place of business at 2150 Ringwood Avenue, San Jose, California 95131("SMI"), (ii) CRYOLIFE, INC., a Florida corporation, having a principal place of business at 1655 Roberts Blvd. NW, Kennesaw, Georgia 30144 ("CryoLife") and (iii) CLOTPLUS LIMITED, a limited company of Ireland having a principal place of business at Regus House, Block 4, Harcourt Road, Dublin2, Ireland ("CPL"). This First Amendment amends that certain Distribution Agreement dated September 28, 2010 between SMI and CryoLife (the "Agreement") and adds CPL as a party for the limited purposes set forth in this First Amendment. When used herein, the term Amended Agreement refers to the Agreement as amended by this First Amendment. To the extent any provision of this First Amendment conflicts with a term of the Agreement, the provisions

NSJ-US. Co., Ltd. – Second Amendment to Distribution Agreement (January 26th, 2012)

THIS SECOND AMENDMENT TO DISTRIBUTION AGREEMENT of twenty-first day of March 2011 by and between NSJ. Co., Ltd., a corporation duly organized under the laws of Japan (hereinafter "SUPPLIER"), and NSJ-US. Co., Ltd., a corporation duly organized under the laws of Nevada, United States (hereinafter "DISTRIBUTOR") is made as of January 1, 2012.

Amendment to Distribution Agreement (October 20th, 2011)

This Amendment to Distribution Agreement (this Amendment) is entered into as of October 14, 2011, by and between ID Biomedical Corporation of Quebec (IDB) and Henry Schein, Inc. (HSI).

NSJ-US. Co., Ltd. – Amendment to Distribution Agreement (October 12th, 2011)

THIS AMENDMENT TO DISTRIBUTION AGREEMENT dated as of September 27, 2011 amending the Distribution Agreement made the twenty-first day of March 2011 by and between NSJ. Co., Ltd., a corporation duly organized under the laws of Japan (hereinafter "SUPPLIER"), and NSJ-US. Co., Ltd., a corporation duly organized under the laws of Nevada, United States (hereinafter "DISTRIBUTOR").

Amendment to Distribution Agreement (September 29th, 2011)

This Amendment (this Amendment) is entered into as of September 27, 2011, by and between ID Biomedical Corporation of Quebec (IDB) and Henry Schein, Inc. (HSI).

Amendment to Distribution Agreement (September 16th, 2011)

This Amendment (this Amendment) is entered into as of September 14th, 2011, by and between ID Biomedical Corporation of Quebec (IDB) and Henry Schein, Inc. (HSI).

Confidential Treatment Requested [***] Confidential Portions of This Agreement Which Have Been Redacted Are Marked With Brackets ([***]). The Omitted Material Has Been Filed Separately With the United States Securities and Exchange Commission. First Amendment to Distribution Agreement (July 29th, 2011)

This FIRST AMENDMENT TO DISTRIBUTION AGREEMENT (this First Amendment) is entered into as of May 18, 2011, by and between (i) STARCH MEDICAL, INC., a Delaware corporation having a principal place of business at 2150 Ringwood Avenue, San Jose, California 95131(SMI), (ii) CRYOLIFE, INC., a Florida corporation, having a principal place of business at 1655 Roberts Blvd. NW, Kennesaw, Georgia 30144 (CryoLife) and (iii) CLOTPLUS LIMITED, a limited company of Ireland having a principal place of business at Regus House, Block 4, Harcourt Road, Dublin2, Ireland (CPL). This First Amendment amends that certain Distribution Agreement dated September 28, 2010 between SMI and CryoLife (the Agreement) and adds CPL as a party for the limited purposes set forth in this First Amendment. When used herein, the term Amended Agreement refers to the Agreement as amended by this First Amendment. To the extent any provision of this First Amendment conflicts with a term of the Agreement, the provisions of this F

Amendment to Distribution Agreement (June 28th, 2011)

This Amendment (this Amendment) is entered into as of June 24, 2011, by and between ID Biomedical Corporation of Quebec (IDB) and Henry Schein, Inc. (HSI).

Deere John Capital Corp – Due Nine Months or More From Date of Issue AMENDMENT TO DISTRIBUTION AGREEMENT (May 27th, 2011)

Reference is made to the Distribution Agreement dated as of February 26, 2009, as amended by the Assignment and Acceptance Agreement dated as of August 12, 2009 (together the Distribution Agreement) between John Deere Capital Corporation (the Company), InCapital LLC (the Purchasing Agent) and Merrill Lynch, Pierce, Fenner & Smith Incorporated (the Agent). The Company, the Purchasing Agent and the Agent agree as follows:

VaxGen – First Amendment to Distribution Agreement (May 13th, 2011)

THIS FIRST AMENDMENT TO THE DISTRIBUTION AGREEMENT (1st Amendment) is effective as of January 1, 2011 (the 1st Amendment Effective Date), by and between Inova Diagnostics, Inc. a California corporation with offices located at 9900 Old Grove Road, San Diego, CA 92131 (DISTRIBUTOR), and diaDexus, Inc., a Delaware corporation with its principal place of business at 343 Oyster Point Blvd., South San Francisco, CA 94080, USA (DIADEXUS).

Liberated Energy, Inc. – Amendment to Distribution Agreement (February 25th, 2011)

THIS AMENDMENT IS MADE TO AN AGREEMENT, made the first day of August, 2010 by and between Lin'an Fengye Food Co., Ltd. , a corporation duly organized under the laws of the People's Republic of China having its principal place of business at Maoli Village, Longgang Town, Lin'an City, Zhejiang Province, 311322 (hereinafter "SUPPLIER"), and Mega World Food Limited, a corporation duly organized under the laws of Hong Kong Special Administration Region of the PRC, with its registered address at ROOM C1D, 6/F, WING HING INDUSTRIAL BUILDING, 14 HING YIP STREET, KWUN TONG, KOWLOON, HONG KONG (hereinafter "DISTRIBUTOR").

Lantheus MI Real Estate, LLC – Confidential Treatment Requested Information for Which Confidential Treatment Has Been Requested Is Omitted and Noted With ****. An Unredacted Version of This Document Has Also Been Provided to the Securities and Exchange Commission. First Amendment to Distribution Agreement (December 1st, 2010)

This First Amendment to Distribution Agreement (this Amendment) is made by and between Bristol-Myers Squibb Medical Imaging, Inc., formerly known as Bristol-Myers Squibb Pharma Company (BMS) and Medi-Physics, Inc., doing business as G.E. Healthcare (G.E. Healthcare) (referred to individually as Party and collectively as Parties) and shall be effective as of January 1, 2005.